Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2300 -0.0100 (-0.81%) 03/24/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2314 +0.0014 (+0.11%) 16:05 ET
for Mon, Mar 24th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
| 06-2019 | 06-2018 | 06-2017 | 06-2016 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,132 | -10,188 | -22,508 | -28,180 | -7,723 |
| Depreciation Amortization | 2,727 | 2,591 | 4,700 | 6,123 | 240 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -24 |
| Accounts receivable | -1,162 | -51 | -355 | -5 | -157 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -607 |
| Other Working Capital | -210 | -719 | -1,042 | 1,792 | -145 |
| Other Operating Activity | 11,946 | -7,574 | 5,375 | 9,614 | 1,782 |
| Operating Cash Flow | $-13,831 | $-15,940 | $-13,830 | $-10,658 | $-6,634 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,072 | -2,013 | N/A |
| PPE Investments | -560 | -475 | -112 | -253 | N/A |
| Net Acquisitions | N/A | N/A | -4,387 | -3,040 | -1,000 |
| Purchase Of Investment | 3 | -2 | N/A | 2 | -5 |
| Other Investing Activity | -505 | -7 | -108 | 0 | 0 |
| Investing Cash Flow | $-1,062 | $-484 | $-3,535 | $-5,304 | $-1,005 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 5,175 | 7,400 |
| Debt Issued | 5,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 15,555 | 25,417 | 2,243 | 5,200 | 5,000 |
| Other Financing Activity | -1,480 | -2,758 | 7,944 | 6,288 | -48 |
| Financing Cash Flow | $19,075 | $22,660 | $10,188 | $16,663 | $12,353 |
| Beginning Cash Position | 7,113 | 878 | 8,054 | 7,353 | 2,640 |
| End Cash Position | 11,294 | 7,113 | 878 | 8,054 | 7,353 |
| Net Cash Flow | $4,182 | $6,235 | $-7,177 | $701 | $4,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,831 | -15,940 | -13,830 | -10,658 | -6,634 |
| Capital Expenditure | -560 | -475 | -112 | -253 | N/A |
| Free Cash Flow | -14,391 | -16,415 | -13,941 | -10,910 | -6,634 |